Transfusion medicine

Transfusion medicine is a multidisciplinary specialty focusing on the proper use of blood components (RBCs, platelets, plasma) for treating diseases, covering blood banking, immunohematology, and donor care. It is vital for treating massive blood loss, cancer, anemia, and surgery support, ensuring blood safety through stringent testing and hemovigilance.

Key Aspects of Transfusion Medicine:

• Blood Component Therapy: Components include packed red blood cells (PRBCs) for low hemoglobin, platelets for clotting, and fresh frozen plasma (FFP) for clotting factors.
• Safety & Compatibility: Procedures involve strict ABO/Rh typing and crossmatching to ensure compatibility, typically using 18–20 gauge IV catheters.
  • Safety Measures: Two nurses must verify blood products before administration. Monitoring for reactions is critical, particularly within the first 15 minutes.
  • Components Administered:
    • PRBCs: Max 4 hours to infuse.
    • Platelets: Administered via a special set with a small filter, ideally within 30 minutes.
    • FFP/Cryoprecipitate: Used to correct coagulation factor deficiencies or fibrinogen deficiencies.
  • Role in Healthcare: It encompasses donor selection, collection, storage, therapeutic apheresis, and stem cell processing.

Specialized Areas:

• Immunohaematology: Studying blood groups and antibodies to prevent hemolytic reactions.
• Hemovigilance: Surveillance system for collecting and analyzing information on adverse reactions to improve transfusion safety.
• Autologous Transfusion: Collecting a patient's own blood prior to surgery to eliminate risk of transfusion reactions.

Transfusion medicine is a multidisciplinary specialty focusing on the proper use of blood components (RBCs, platelets, plasma) for treating diseases, covering blood banking, immunohematology, and donor care. It is vital for treating massive blood loss, cancer, anemia, and surgery support, ensuring blood safety through stringent testing and hemovigilance.

Key Aspects of Transfusion Medicine:

• Blood Component Therapy: Components include packed red blood cells (PRBCs) for low hemoglobin, platelets for clotting, and fresh frozen plasma (FFP) for clotting factors.
• Safety & Compatibility: Procedures involve strict ABO/Rh typing and crossmatching to ensure compatibility, typically using 18–20 gauge IV catheters.
  • Safety Measures: Two nurses must verify blood products before administration. Monitoring for reactions is critical, particularly within the first 15 minutes.
  • Components Administered:
    • PRBCs: Max 4 hours to infuse.
    • Platelets: Administered via a special set with a small filter, ideally within 30 minutes.
    • FFP/Cryoprecipitate: Used to correct coagulation factor deficiencies or fibrinogen deficiencies.
  • Role in Healthcare: It encompasses donor selection, collection, storage, therapeutic apheresis, and stem cell processing.

Specialized Areas:

• Immunohaematology: Studying blood groups and antibodies to prevent hemolytic reactions.
• Hemovigilance: Surveillance system for collecting and analyzing information on adverse reactions to improve transfusion safety.
• Autologous Transfusion: Collecting a patient's own blood prior to surgery to eliminate risk of transfusion reactions.